Compared to that in controls, the expression levels of MPO exhibited a significant decrease in patients with MM across the GSE6477 dataset (p = 3.2e−09), the GSE24870 dataset (p = 0.0015) and the GSE125361 dataset (p = 0.006; Figure 5B–D). This evidence concerns the gene MPO and Miyoshi myopathy.